Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iSPASM-2: Tirofiban in Aneurysmal Subarachnoid Hemorrhage
NCT07493577Phase 2Not yet recruiting
- Start
- Dec 2026
- Primary completion
- May 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tirofiban in aneurysmal subarachnoid hemorrhage (SAH). Planned start Dec 2026; status: not yet recruiting.
02
Drugs
tirofiban
03
Conditions
aneurysmal subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT07493577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07493577.